Cannabis Shows Promise for Inflammatory Bowel Disease But Needs Larger Clinical Trials
Cannabis interacts with CB1 and CB2 receptors throughout the gut and immune system to reduce inflammation, motility, and secretions, showing symptomatic benefits in small IBD studies, but large controlled trials are still lacking.
Quick Facts
What This Study Found
Cannabinoids act on CB1 and CB2 receptors in the enteric nervous system, GI epithelial cells, and immune cells, reducing gut motility, secretions, and inflammatory edema. Small observational studies and placebo-controlled trials have shown symptomatic improvement, but sample sizes have been too small for firm efficacy and safety conclusions.
Key Numbers
CB1 and CB2 receptors expressed in brain, enteric nervous system, GI epithelial cells, and immune cells; effects: decreased gut motility, reduced secretions, reduced inflammatory edema
How They Did This
Narrative review of observational and placebo-controlled trials examining cannabis and cannabinoids in Crohn's disease and ulcerative colitis, alongside preclinical mechanism data.
Why This Research Matters
IBD affects millions of people globally, and current treatments often have significant side effects or lose effectiveness over time. Cannabis represents a potentially well-tolerated complementary approach, but the evidence gap is significant.
The Bigger Picture
The endocannabinoid system's extensive presence in the gut provides a strong biological rationale for cannabinoid therapy in IBD. The challenge is moving from preclinical promise to clinical evidence through adequately powered trials.
What This Study Doesn't Tell Us
Narrative review. Existing clinical trials have small sample sizes. No standardized cannabinoid compositions across studies. Long-term safety data lacking. Psychotropic side effects of THC limit some applications.
Questions This Raises
- ?Would standardized cannabis preparations with specific cannabinoid ratios be more effective for IBD?
- ?Could cannabis derivatives without psychoactive effects provide the anti-inflammatory benefits needed?
Trust & Context
- Key Stat:
- Cannabinoids reduce gut motility, secretions, and inflammatory edema through CB1 and CB2 receptors
- Evidence Grade:
- Narrative review of small clinical studies. Biological rationale is strong but clinical evidence remains limited.
- Study Age:
- Published in 2024.
- Original Title:
- The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective.
- Published In:
- Cureus, 16(10), e71068 (2024)
- Authors:
- Rauf, Arsalan, Nisar, Mudassar, Shaeel, Muhammad, Athar, Ali, Rehman, Muhammad Mujtaba Ur, Faheem, Filzah
- Database ID:
- RTHC-05643
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Can cannabis help with IBD?
Small studies show symptomatic improvement, and the biological mechanism is well-understood. But evidence from large controlled trials is still lacking.
How does cannabis work in the gut?
Cannabis compounds interact with CB1 and CB2 receptors in the gut to reduce inflammation, slow motility, and decrease secretions.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05643APA
Rauf, Arsalan; Nisar, Mudassar; Shaeel, Muhammad; Athar, Ali; Rehman, Muhammad Mujtaba Ur; Faheem, Filzah. (2024). The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective.. Cureus, 16(10), e71068. https://doi.org/10.7759/cureus.71068
MLA
Rauf, Arsalan, et al. "The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective.." Cureus, 2024. https://doi.org/10.7759/cureus.71068
RethinkTHC
RethinkTHC Research Database. "The Potential of Cannabis in Managing Inflammatory Bowel Dis..." RTHC-05643. Retrieved from https://rethinkthc.com/research/rauf-2024-the-potential-of-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.